Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
GHRS compared with COAG: revenue, margins and what each company keeps, and the suppliers and customers both name
GHRS
GH Research PLC
Change
Mkt cap
Revenue
Revenue
COAG
Hemab Therapeutics Holdings, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
GHRS
GH Research PLC
vs
COAG
Hemab Therapeutics Holdings, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
GHRS: latest quarter not drawable. COAG: latest quarter not drawable.
Method
›
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
GHRS, solid
COAG, dashed
GHRS
GH Research PLC
Change
20.67
▼
−3.86%
· post 20.67
Mkt cap
$1.3B
COAG
Hemab Therapeutics Holdings, Inc.
Change
41.49
▲
+2.65%
· post 41.49
Closed
Oct 30 '26
Mkt cap
$1.2B
vs
Compare
Closed
Oct 30 '26
GHRS
GH Research PLC
vs
COAG
Hemab Therapeutics Holdings, Inc.
20.67
▼
−3.86%
post 20.67
Price
41.49
▲
+2.65%
post 41.49
$1.3B
Mkt cap
$1.2B
Change
Change
GHRS
20.67
▼
−3.86%
vs
COAG
41.49
▲
+2.65%
Closed
Oct 30 '26
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only GHRS
0
None
Shared
0
No disclosed counterparties: GHRS.
Only COAG
2
NVO
Novo Nordisk A/S
supplier
GMAB
Genmab A/S
supplier
Role chip = supplier or customer
Source: SEC EDGAR